Speed and Reliability in Medical Device Development Facilitated by Balancing Proper Design with Highly Functional Prototyping MaterialsJune 23, 2010 7:20 am | by Scott Castanon | Comments
This case study will focus on the vital role played by WaterShed XC 11122, a rapid prototyping resin from DSM Somos, which helps to ensure a remarkably fast turnaround coupled with the ability to replicate actual performance attributes of production-grade engineered thermoplastics. Two words best encompass a ch
In comparison with conventional laser technologies, the primary benefits of fiber lasers are their ease of use, straightforward integration capability, high reliability, and maintenance free operation. However, as discussed in this article, SPI’s latest generation of R-4 CW-M High Power Fiber Lasers have many other fe
What once seemed a far-off goal for mold and die work, as well as medical parts, is now a reality, based on new technologies you can investigate today. The challenge had always been threefold for mold and die work and medical parts machining, especially those medical parts in the highly competitive and materi
This article will highlight key attributes of certain silicones, as well as key considerations when selecting a silicone. As one of the most widely researched biomaterials to date, silicone has an approximate 50-year legacy of use in the healthcare industry. This history of biocompatibility has made silicone
Cardiac ablation is used extensively for treating cardiac arrhythmia, but has been hindered by the lack of an adequate feedback mechanism for determining tissue temperature during ablation. This article describes a system based on microwave sensing technology that allows both heating at RF or microwave frequencie
By taking existing technologies, and reimagining them within a new context, scientists and manufacturers are able to produce innovative solutions to many everyday problems. For example, the efforts of a professor from the University of Washington, the Optiva Corporation, and Morgan Electro Ceramics have yielded a grou
The global market for mass spectrometry, already surpassing $3 billion, is expected to grow by eight percent per year through the end of the decade, according to Spectroscopy Magazine and Instrument Business Outlook. The growth is fueled by continual advancements in technology, which have positioned mass spectrometry
The following article identifies the benefits of bringing in outside maintenance expertise to perform functions that otherwise consume resources that can be better used in a production mode. Ron Hoffman With today's limited
In the fiercely competitive medical device and instrumentation industry, speeding time to market is important to edge out competitors and begin generating revenue for products that often carry long and expensive research and development cycles. Pushing products through the development
When the Wall Street Journal, New York Times, Business Week, and USA Today all have articles discussing the most recent entrant to the Personal Health Record (PHR) space, then something significant might be happening. Regardless of Google’s success in its
DNA has begun to be considered as a possibility for molecular electronics. At Israel’s Weizmann Institute of Science, scanning probe microscopy and negative stiffness vibration isolation enables nano level DNA research. by Jim McMahon Because DNA is able to recognize
Total cost of ownership in sync with Pre Growth strategies With the economic outlook today, it would appear that controllers and engineers are in direct opposition when searching for methods to enhance the bottom line. Controllers want to reduce expenditures
With commercial survival at the top of everyone’s agenda, many medical device and equipment manufacturers are looking to antimicrobial technology to give their product the edge, or to help them diversify into new markets. As BioCote’s sales manager Graham Harvey
The healthcare and life science industries are going through a change in methodology of treatment and cost containment pressures under a focused government controlled or nationally administered health insurance program. These new pressure points are making the pharmaceutical and medical device industry re-evaluate target therapy, point of administration, method of administration, portability of the product, country of origin, associated costs, and convenience for use.
Power sources for medical devices must accommodate numerous requirements, from duration to size to durability. The market offers a plethora of choices of both primary (non-rechargeable) and secondary (rechargeable) batteries in a great variety of shapes, sizes, and chemistries. This article focuses on design considerations for primary cells, with a brief look at secondary cells.